TerSera Therapeutics is a biopharmaceutical company committed to enhancing patient care by building innovative therapies and ensuring their delivery to those in need. The company focuses on developing patient-first solutions backed by scientific expertise and comprehensive support services, aiming for meaningful outcomes in healthcare. TerSera recently acquired MARGENZA® (margetuximab-cmkb), expanding its portfolio of unique therapeutics. Dedicated to addressing unmet medical needs, TerSera leverages its knowledge in advancing one-of-a-kind treatments, striving for significant impacts in human health.
Specialty Pharmaceuticals • Drug Device Combinations • CNS Disorders • Urology • Women's Health
November 4
Directs marketing strategies for TerSera's rare disease portfolio.
November 4
Lead Specialty Account Managers at TerSera Therapeutics in rare disease sales.